Trial in progress: Phase 1a/b study of PF-07284890 (brain-penetrant BRAF inhibitor) with/without binimetinib in patients with BRAF V600-mutant solid tumors.

Vivek Subbiah, Yan Xing, Carey K. Anders et al.|Journal of Clinical Oncology|2021

Cited by 8